BUE Equity Snapshot

PFE Weekly Equity Report

Pfizer Inc.

Interactive chart JSON snapshot
Latest Close 9,770 ARS 12 Jun 2026
1W Return -0.5% latest completed week
4W Return 4.2% short-term follow-through
12W Return -1.2% quarterly tape
Trend Breadth 73.1% 38 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
Company Brief

What the company does

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and …

Snapshot

What the weekly tape is saying

PFE closed the latest completed week at 9,770 ARS. The 4-week return is 4.2% and the 12-week return is -1.2%. Trend Signal is inactive, Market Dynamics is -0.94. Setup signature: Risk-first tape with a 38/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -0.6%
Volume 0.8x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 40 Persistence of active Trend Signal over the last year and current streak.
Momentum 58 Blend of 4-week and 12-week follow-through.
Dynamics 32 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 32 Participation compared with the 13-week volume baseline.
Risk Control 66 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
9,833 ARS
Vs Trend Line
-0.6%
Fair Value
9,469 ARS
Vs Fair Value
3.2%
52W High
10,800 ARS
52W Low
6,630 ARS
Drawdown
-9.5%
Range Position
75.3%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -0.5%
4W 4.2%
12W -1.2%
26W -0.1%
52W 33.8%

Trend read

Active Streak
0 weeks
52W Active Weeks
38
52W Active Breadth
73.1%
Sector Scope
AR Healthcare
Sector Rank
9 of 20
Sector Percentile
57.9%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.94
4W MD Change
-9.9%
Relative Strength
-20.85
4W RS Change
-248.5%
Expectation
Positive
Probability
56.03%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
81.4K
13W Average
106.0K
52W Average
129.6K
Vs 13W
0.8x
Vs 52W
0.6x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.2%
52W Volatility
4.5%
Upside Weeks
34
Downside Weeks
18
Downside Breadth
34.6%
Avg Gain / Loss
2.9% / -3.5%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
BUE
Country
AR
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
ARS
Market Cap
27271.8B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 9,770 ARS -0.5% 9,833 ARS 9,469 ARS -0.94 -20.85 81.4K Off
5 Jun 2026 9,815 ARS 1.3% 9,820 ARS 9,472 ARS -0.96 -13.80 122.1K Off
29 May 2026 9,685 ARS 0.7% 9,792 ARS 9,471 ARS -0.97 -17.17 97.5K Off
22 May 2026 9,615 ARS 2.5% 9,778 ARS 9,470 ARS -0.98 -8.54 79.5K Off
15 May 2026 9,380 ARS -1.5% 9,782 ARS 9,469 ARS -0.86 -5.98 141.3K Off
8 May 2026 9,525 ARS -4.8% 9,784 ARS 9,468 ARS -0.79 -6.36 180.7K On
1 May 2026 10,010 ARS -0.9% 9,776 ARS 9,463 ARS -0.82 -3.61 70.7K On
24 Apr 2026 10,100 ARS 0.5% 9,791 ARS 9,454 ARS -0.49 -2.98 87.3K On
17 Apr 2026 10,050 ARS 1.6% 9,745 ARS 9,446 ARS -0.49 -4.85 105.2K On
10 Apr 2026 9,895 ARS -6.9% 9,723 ARS 9,440 ARS -0.51 -9.50 103.1K On
3 Apr 2026 10,630 ARS 6.6% 9,688 ARS 9,430 ARS -0.53 -2.77 130.9K On
27 Mar 2026 9,975 ARS 0.9% 9,621 ARS 9,416 ARS -0.73 -2.11 77.8K On
20 Mar 2026 9,890 ARS 1.3% 9,568 ARS 9,405 ARS -0.57 -0.45 101.0K On
13 Mar 2026 9,765 ARS -1.6% 9,524 ARS 9,392 ARS -0.59 1.46 113.1K On